🇺🇸 FDA
Patent

US 10478435

Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury

granted A61KA61K31/415A61K31/422

Quick answer

US patent 10478435 (Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury) held by United States Government as represented by the Department of Veterans Affairs expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/415, A61K31/422, A61K31/425, A61K31/427